Omega Supreme 820 (120 Capsules)


Omega Supreme 820 is one of the most highly concentrated, pharmaceutical grade, non-prescription, ultra-pure, great-tasting fish oils in the professional marketplace. Every batch of this molecularly–distilled oil undergoes independent third party testing for purity and freshness. The 820 mgs of omega-3 oil in each softgel with lemon coating is from anchovies and sardines and is stabilized with vitamin E.

All Arthritis Center Of Riverside® Formulas Meet or Exceed cGMP quality Standards.


Take one or two softgels, one to three times daily, or as directed by your healthcare practitioner.


Consult your healthcare practitioner before use. Keep out of reach of children. Avoid if allergic to any ingredient.

SKU: 1014 Category:



At the same time as the media increases consumer awareness of the importance of fish oils, manufacturers face the challenge of eliminating heavy metals and PCBs. The industry- leading technologies used in the preparation of Omega Supreme 820 surpass all national and international standards for environmental pollutants, including dioxins, PCBs, pesticides and heavy metals, including mercury.

The process of making Omega Supreme 820 starts with sourcing oils from fresh, cold water, deep-sea, wild-caught, clean sardines and anchovies. Then the oil undergoes an exceptionally rigorous purification, manufacturing and verification processes to reduce any potential health risks due to exposure to rancid fats, toxins bacteria, molds and yeasts, or very high levels of fat-soluble vitamins. The molecular distillation purification process used is a proprietary, temperature-regulated, vacuum technology in accordance with pharmaceutical standards. This assures safe, consistent, ultra-pure fish oil. The Omega Supreme 820 formula exceeds the Council for Responsible Nutrition (CRN) Monograph standards and meets all international standards for oil safety including WHO, Prop 65 and more. It is third-party tested in accordance with AOCS (American Oil Chemical Scientists) International protocols to ensure purity and potency.

The oil in the Omega Supreme 820 formula is stabilized with the addition of vitamin E and is delivered in non-enteric-coated softgels. The formula is pleasant to consume thanks to the lemon flavor that coats the softgels and not a hint of fish smell or taste. Each softgel of Omega Supreme 820 contains 500 mg of Eicosapaentenoic Acid (EPA) and 320 mg of Docosopentaenoic Acid concentrated from 1.4 grams of the marine fish oil, making it convenient when higher amounts of EPA and DHA are desirable.

The formula does not contain any gluten, corn protein, yeast, dairy, artificial colors, sweeteners or preservatives. The vitamin E is derived from soy.

1. Calder PC.n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond). 2004 Jul;107(1):1-11 [PMID: 15132735]

2. Storey A, et al. Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF-alpha-induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibroblasts. J Invest Dermatol. 2005 Jan;124(1):248-55. [PMID: 15654981]

3. Kim YJ, Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sci.2006 Apr 18;78(21):2523-32. Epub 2006 Jan 24 [PMID: 16438990]

4. Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol. 2006 Apr;65(4):326-31 [PMID: 16531187]

5. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006 Jan;188:46-50. [PMID: 16388069]

6. Kankaanpaa P, et al. Dietary fatty acids and allergy. Ann Med. 1999 Aug;31(4):282-7. [PMID: 10480759]

7. Ebbesson SO, et al. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the

8. Alaska Siberia project. Int J Circumpolar Health. 2005 Sep;64(4):396-408. [PMID: 16277123] Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc. 2005 Mar;105(3):428-40 [PMID: 15746832]

9. International Society for the Study of Fats and Lipids (ISSFAL, 2002)

10. Arterburn, LM. Dosing and distribution of n-3 fatty acids in humans. Presented at the Omega-3 fatty acids: Recommendations for therapeutics and prevention symposium. May 21, 2005. New York {accessed 6.9.06}
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or 
prevent any disease.